Skip to main content

Table 2 Comparison of patients infected with slow-growing or rapidly growing NTM

From: Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis

  Patients with Slow-growing NTM (N = 17) Patients with Rapidly Growing NTM (N = 8)
N Median (range) P-value N Median (range) P-value
Body mass index in kg/m2 16   0.35 8   0.069
 Before NTM infection   19.8 (15.0–23.9)   19.3 (14.7–21.7)
 After NTM infection   19.6 (15.2–25.9)   20.4 (15.1–21.7)
FEV1 percent predicted 17   0.11 7   0.23
 Before NTM infection   92 (53–115)   84 (71–102)
 After NTM infection   91 (36–110)   82 (48–91)
FEF25–75% predicted 17   0.013 7   0.028
 Before NTM infection   79 (24–124)   64 (42–123)
 After NTM infection   68 (13–110)   51 (24–103)
IgE in kU/L 16   0.55 7   0.61
 Before NTM infection   34 (8–2165)   95 (18–419)
 After NTM infection   34 (9–1340)   182 (57–429)
Vitamin A in μg/dL 11   0.19 5   0.23
 Before NTM infection   39 (19–83)   33 (15–45)
 After NTM infection   45 (25–79)   30 (12–41)
Vitamin E in mg/L 9   0.37 5   0.50
 Before NTM infection   8 (2–13)   7 (6–11)
 After NTM infection   9 (2–14)   5 (4–12)
\